Angel Biotechnology will develop and manufacture a recombinant interferon product for TransGenRx at its Cranlingon, UK, faulty. As part of the £800,000 deal Angel will work to attain acceptable expression levels on which to establish a GMP manufacturing process, which would then be conducted by Angel.
Angel Biotechnology
Tuesday 24 April 2012
£800k deal for Angel
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment